| 영문 | radiation therapy | 한글 | 방사선요법 |
|---|---|---|---|
| 설명 | X선, γ선의 전자방사선이나 전자선, 양자선, 중성자선 등의 입자방사선을 이용해, 주로 악성 종양 치료를 목적으로 하는 치료법이다. 암세포가 주위의 정상세포보다도 방사선 감수성이 높은 점을 이용하여, 정상세포의 손상을 가능한 한 최소로 억제하면서 암세포를 파괴한다. 사용되는 방사선에는 밀봉소선원에서 나오는 γ선, 직선가속기에서 얻어지는 고에너지 X선과 전자선, 텔레코발트장치에 의한 60Co의 γ선과, 베타트론에 의한 전자선, 사이크로트론에서 얻어지는 양자선, 중성자선 등이 있다. |
||
| 영문 | radiation therapy | 한글 | 방사선치료 |
|---|---|---|---|
| 설명 | 방사선의 살균효과나 세포를 죽이는 효과를 치료에 이용하는 방법으로, 좁은 의미로 암의 방사선치료를 의미한다. 암에 대한 방사선치료는 암세포를 죽이는데 효과가 큰 베타선을 주로 사용한다. 하지만, 이런 방사선치료는 정상세포에도 큰 영향을 끼쳐 이에 따른 기능의 장애를 가져올 수 있다. 따라서 방사선치료에 있어서는 단지 그 암세포에 대한 작용뿐만 아니라, 정상세포에 대한 작용도 고려하여 시행한다. |
||
| 영문 | speech therapy | 한글 | 언어치료 |
|---|---|---|---|
| 설명 | 말을 정확하게 발음할 수 없거나 더듬는 환자에게 발음, 대화 따위의 훈련을 전문적으로 행하는 치료법. |
||
| 영문 | therapy | 한글 | 요법 |
|---|---|---|---|
| 설명 | 병을 낫게 하는 것 또는 그 방법. |
||
| 영문 | gene therapy | 한글 | 유전자요법 |
|---|---|---|---|
| 설명 | 유전병을 치료할 목적으로, 정상적으로 기능하는 단일유전자 혹은 복수유전자를 어떤 기원에서 얻어내어 생세포에 도입하는 것. 유전물질은 유전자삽입 조작에 의해 수용세포에로 도입된다. 즉, 유전자를 끼워 넣은 새로운 세포를 사용하는 치료로서 1980년 미국의 학자가 지중해빈혈환자에게 강행하여 비판을 받았지만, 미국 국립보건연구소는 1990년 9월 아데노신 데아미나아제(adenosine deaminase, ADA) 결핍증 환자의 림프구에 ADA 유전자를 끼워 넣는 치료를 시작한 이래 현재는 암을 포함한 많은 질병들을 치료하는 목적으로 쓰인다. |
||
| ACIP | acute canine idiopathic polyneuropathy; Advisory Committee on Immunization Practices [CDC] |
|---|---|
| DPI | daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni... |
| EPI | echo planar imaging; electronic portal imaging; Emotion Profile Index; epilepsy; epinephrine; epithe... |
| immun | immune, immunity, immunization |
| IR | drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat... |
| dtap immunization | Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. DTaP is the same as DTP, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. DTaP is currently recommended only for the shots given at 18 months and 4-6 years of age. (12 Dec 1998) |
|---|---|
| dt immunization | DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a DPT shot or who have a personal or family history of a seizure disorder or brain disease. (12 Dec 1998) |
| immunization | <immunology> A process that increases an organisms reaction to antigen and therefore improves its ability to resist or overcome infection. <technique> A technique used to induce immune resistance to a specific disease in humans (or other mammals) by exposing the individual to an antigen in order to raise antibodies to that antigen. (13 Oct 1997) |
| immunization, anthrax | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| immunization, chickenpox | This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination. (12 Dec 1998) |
| immunization, children's | In the United States, it is recommended that all children receive vaccination against: hepatitis b diphtheria, tetanus, pertussis haemophilus influenzae type b (hib) poliovirus measles, mumps, rubella varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| immunization, dpt | DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also immunization, dtap. (12 Dec 1998) |
| immunization, dt | DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease. (12 Dec 1998) |
| immunization, dtap | Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. (12 Dec 1998) |
| immunization, flu | The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine. (12 Dec 1998) |
| immunization, german measles | See Immunization, MMR. (12 Dec 1998) |
| immunization, haemophilus influenzae type b | See immunization, hib. (12 Dec 1998) |
| immunization, hepatitis a | When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. (12 Dec 1998) |
| immunization, hepatitis b | Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection. (12 Dec 1998) |
| immunization, h. flu | See Immunization, HIB. (12 Dec 1998) |